Form 4: Cytosorbents Corp Executive Vincent Capponi Reports Acquisition of Shares and Stock Options

Vincent Capponi, President and COO of Cytosorbents Corp, reports the acquisition of 81,000 shares of common stock and 101,000 stock options.

Summary

• On April 2, 2024, Vincent Capponi, President and COO of Cytosorbents Corp, acquired 81,000 shares of common stock and 101,000 stock options.
• The 81,000 shares represent restricted stock units (RSUs) that will vest in equal parts on the first and second year anniversaries of the grant date.
• The 101,000 stock options, with an exercise price of $0.955, vest over three years: one-half on the first anniversary, one-fourth on the second, and one-fourth on the third anniversary.
• Capponi directly owns 665,134 shares of Common Stock following the reported transactions.
• The stock options were granted pursuant to the company's 2014 Long-Term Incentive Plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and options by an executive is generally a good sign, but it's a routine transaction.

Positives

• The acquisition of shares and stock options by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.
• The vesting schedules for both the RSUs and stock options incentivize continued service and commitment from the executive.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Insider ownership is a common metric used to assess alignment between management and shareholders.
• Comparing Capponi's ownership stake to those of executives at similar medical device companies (e.g., Baxter International, Medtronic) could provide context on whether his holdings are typical or indicative of stronger conviction.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a key executive.

Key Dates